Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Prasad

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Cell Death & Disease|September 22, 2018
IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancerJonatan Zorea, Manu Prasad, Limor Cohen, et al.
Annals of Maxillofacial Surgery|January 8, 2020
Clonidine: An Adjuvant to Adrenaline in Local Anesthesia for Third Molar SurgeryShahbaz Alam, B Pramod Krishna, Santosh Kumaran, et al.
Archives of Oral Biology|June 5, 2017
Differential expression of transcription factors NF-κB and STAT3 in periodontal ligament fibroblasts and gingiva of healthy and diseased individualsR Ambili, Presanthila Janam, P S Saneesh Babu, et al.
JCI Insight|March 13, 2019
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapyMai Badarni, Manu Prasad, Noa Balaban, et al.
Journal of Ethnopharmacology|December 21, 2016
An ex vivo evaluation of the efficacy of andrographolide in modulating differential expression of transcription factors and target genes in periodontal cells and its potential role in treating periodontal diseasesAmbili R, Prasanthila Janam, P S Saneesh Babu, et al.
Cancers|July 24, 2021
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, et al.
Cancers|February 8, 2020
TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck CancerKsenia M Yegodayev, Ofra Novoplansky, Artemiy Golden, et al.
Frontiers in Oncology|February 7, 2019
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted TherapySusmita Ghosh, Manu Prasad, Kiran Kundu, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 20, 2024
Dual inhibition of HERs and PD-1 counteract resistance in KRAS<sup>G12C</sup>-mutant head and neck cancerOfra Novoplansky, Sankar Jagadeeshan, Manu Prasad, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Cell Death & Disease|September 22, 2018
IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancerJonatan Zorea, Manu Prasad, Limor Cohen, et al.
Annals of Maxillofacial Surgery|January 8, 2020
Clonidine: An Adjuvant to Adrenaline in Local Anesthesia for Third Molar SurgeryShahbaz Alam, B Pramod Krishna, Santosh Kumaran, et al.
Archives of Oral Biology|June 5, 2017
Differential expression of transcription factors NF-κB and STAT3 in periodontal ligament fibroblasts and gingiva of healthy and diseased individualsR Ambili, Presanthila Janam, P S Saneesh Babu, et al.
JCI Insight|March 13, 2019
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapyMai Badarni, Manu Prasad, Noa Balaban, et al.
Journal of Ethnopharmacology|December 21, 2016
An ex vivo evaluation of the efficacy of andrographolide in modulating differential expression of transcription factors and target genes in periodontal cells and its potential role in treating periodontal diseasesAmbili R, Prasanthila Janam, P S Saneesh Babu, et al.
Cancers|July 24, 2021
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, et al.
Cancers|February 8, 2020
TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck CancerKsenia M Yegodayev, Ofra Novoplansky, Artemiy Golden, et al.
Frontiers in Oncology|February 7, 2019
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted TherapySusmita Ghosh, Manu Prasad, Kiran Kundu, et al.
International Journal of Cancer|January 30, 2019
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancerOfra Novoplansky, Matthew Fury, Manu Prasad, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 20, 2024
Dual inhibition of HERs and PD-1 counteract resistance in KRAS<sup>G12C</sup>-mutant head and neck cancerOfra Novoplansky, Sankar Jagadeeshan, Manu Prasad, et al.
Pageof 3